Citation only
via OpenAlex
Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?
Giuseppe Cianciolo, Andrea Galassi, Irene Capelli, Roberto Schillaci, Gaetano La Manna, Mario Gennaro Cozzolino
Current Vascular Pharmacology · 2017 · ▲ 55 citations
Abstract
BACKGROUND: Patients affected by Chronic Kidney Disease and Mineral Bone Disorder (CKD-MBD) have a high risk of cardiovascular (CV) mortality that is poorly explained by traditional risk factors. The newest medical treatments for CKD-MBD have been associated with encouraging, but still inconsistent, improvement in CV disease complications and patient survival. A better understanding of the biomarkers and mechanisms of left ventricular hypertrophy (LVH), atherosclerosis, and vascular calcification (VC) may help with diagnosis and treatment of the organ damage that occurs secondary to CKD-MBD, thus improving survival. Recent insights about fibroblast growth factor-23 (FGF23) and its co-receptor, Klotho, have led to marked advancement in interpreting data on vascular aging and CKDMBD. CONCLUSION: This review will discuss the current experimental and clinical evidence regarding FGF23 and Klotho, with a particular focus on their roles in LVH, atherosclerosis, and VC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/1570161115666170310092202
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Cianciolo, G., Galassi, A., Capelli, I., Schillaci, R., Manna, G.L., & Cozzolino, M.G. (2017). Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?. <em>Current Vascular Pharmacology</em>. https://doi.org/10.2174/1570161115666170310092202
Vancouver
Cianciolo G, Galassi A, Capelli I, Schillaci R, Manna GL, Cozzolino MG. Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?. Current Vascular Pharmacology. 2017. doi:10.2174/1570161115666170310092202.
BibTeX
@article{giuseppe2017Klotho,
title = {Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?},
author = {Giuseppe Cianciolo and Andrea Galassi and Irene Capelli and Roberto Schillaci and Gaetano La Manna and Mario Gennaro Cozzolino},
journal = {Current Vascular Pharmacology},
year = {2017},
doi = {10.2174/1570161115666170310092202},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 2017
Preprint
[Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
PubMed 2015
Preprint · CC-BY
Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease.
Bone 2016
Preprint · OA
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Frontiers in Genetics 2017
Open access · CC-BY
The Role of MicroRNAs in Arterial Stiffness and Arterial Calcification. An Update and Review of the Literature
Clinical Kidney Journal 2023
Open access · CC-BY
Is there a role in acute kidney injury for FGF23 and Klotho?
Contributions to nephrology 2015
Citation only